Zoetis (NYSE: ZTS) Plummets 21.5% After Slashing 2026 Guidance on U.S. Pet Demand

Zoetis Inc. crashed 21.5% to $87.31 after the animal health company cut its 2026 full-year guidance, citing softer-than-expected U.S. pet owner spending and demand softness that signals broader consumer caution.

Q1 2026 At a Glance

• Revenue growth of just 1.9% year-over-year, marking a dramatic deceleration and the steepest slowdown in the company's recent history
• Earnings growth of 0.7% year-over-year, nearly flat and indicating profit expansion is stalling
• Profit margin of 28.03%, still healthy but under pressure from volume deceleration
• Forward P/E of 11.63x, now offering single-digit valuation after the repricing

What Drove the Results

Zoetis's sharp sell-off reflects a critical inflection point in U.S. pet spending. The company's Q1 revenue growth of just 1.9%—versus historical mid-single-digit baseline expectations—signals pet owners are pulling back on veterinary care, medications, and diagnostics. This is a canary-in-the-coal-mine indicator for consumer health, suggesting discretionary healthcare spending is being deferred as household budgets tighten.

The guidance cut signals management's loss of confidence in near-term demand recovery. Unlike prior slowdowns that were temporary, this reduction suggests structural softness in U.S. pet spending rather than seasonal fluctuation. Zoetis has limited pricing power if volumes are falling—the company cannot offset volume declines with price increases without further eroding demand.

Investor Takeaway

Zoetis's 21% collapse is justified. The combination of 2% revenue growth, guidance cuts, and near-flat earnings growth signals the bull case has deteriorated materially. While the forward P/E of 11.6x appears cheap, it reflects appropriate repricing for a company with no growth momentum. U.S. pet spending slowdown is a leading indicator of consumer stress; if Zoetis demand remains soft through Q2, it could signal deeper consumer weakness ahead. Value investors should avoid catching this falling knife until at least two consecutive quarters demonstrate stabilization in revenue growth.